{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:15:33Z","timestamp":1787030133693,"version":"build-2736575974"},"reference-count":31,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development (AMED)","doi-asserted-by":"publisher","award":["20fk0108099s0202"],"award-info":[{"award-number":["20fk0108099s0202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Increasing numbers of patients with zoster were reported recently, and recombinant zoster vaccine (Shingrix\u00ae) was licensed using the AS01B adjuvant system. Although it induces highly effective protection, a high incidence of local adverse events (regional pain, erythema, and swelling) has been reported with systemic reactions of fever, fatigue, and headache. To investigate the mechanism of local adverse events, cytokine profiles were investigated in mice injected with 0.1 mL of Shingrix\u00ae. Muscle tissue and serum samples were obtained on days 0, 1, 3, 5, and 7, and at 2 and 4 weeks after the first dose. The second dose was given 4 weeks after the first dose and samples were obtained on days 1, 3, 5, 7, and 14. IL-6 and G-CSF were detected in muscle tissues on day 1 of the first injection, decreased on day 3 and afterward, and enhanced production was demonstrated on day 1 of the second dose. In sera, the elevated levels of IL-6 were detected on day 1 of the first dose, and IL-10 was detected on day 1 with increased levels on day 3 of the first dose. IL-4 was detected in muscle tissue on day 1 of the second dose and IL-5 on day 1 of both the first and second doses. IFN-\u03b3 production was not enhanced in muscle tissue but increased in serum samples on day 1 of the first dose. These results in the mouse model indicate that the induction of inflammatory cytokines is related to the cause of adverse events in humans.<\/jats:p>","DOI":"10.3390\/vaccines10081339","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T02:48:23Z","timestamp":1660877303000},"page":"1339","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice"],"prefix":"10.3390","volume":"10","author":[{"given":"Tetsuo","family":"Nakayama","sequence":"first","affiliation":[{"name":"Laboratory of Viral Infection, \u00d6mura Satoshi Memorial Institute, Tokyo 108-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Sawada","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Infection, \u00d6mura Satoshi Memorial Institute, Tokyo 108-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Infection, \u00d6mura Satoshi Memorial Institute, Tokyo 108-8641, Japan"},{"name":"Department of Pediatrics, Kitasato University Hospital, Sagamihara 252-0329, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"ref_1","first-page":"2773","article-title":"Varicella-zoster virus replication, pathogenesis, and management","volume":"2","author":"Cohen","year":"2006","journal-title":"Fields Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kennedy, P.G.E., and Gershon, A.A. (2018). Clinical features of varicella-zoster virus infection. Viruses, 10.","DOI":"10.3390\/v10110609"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: Consensus recommendations for infection reporting during clinical trials and postmarketing surveillance","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","article-title":"Examination of links between herpes zoster incidence and childhood varicella vaccination","volume":"159","author":"Hales","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: Evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults \u226550 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_12","first-page":"CD008858","article-title":"Vaccines for preventing herpes zoster in older adults","volume":"2019","author":"Gagliardi","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40264-017-0574-6","article-title":"Suspected adverse effects after human papillomavirus vaccination: A temporal relationship between vaccine administration and the appearance of symptoms in Japan","volume":"40","author":"Ozawa","year":"2017","journal-title":"Drug Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pvr.2018.02.002","article-title":"No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study","volume":"5","author":"Suzuki","year":"2018","journal-title":"Papillomavirus Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/1348-0421.12566","article-title":"Long-term regulation of local cytokine production following immunization in mice","volume":"62","author":"Nakayama","year":"2018","journal-title":"Microbiol. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: Helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Exp. Rev. Vaccines"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/irv.12509","article-title":"Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination","volume":"12","author":"Talaat","year":"2018","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1152\/japplphysiol.01005.2001","article-title":"Invited review: Cytokine regulation of fever: Studies using gene knockout mice","volume":"92","author":"Leon","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(03)00358-3","article-title":"Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress","volume":"20","author":"Chen","year":"2004","journal-title":"Immunity"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4161\/hv.27264","article-title":"Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines","volume":"10","author":"Kashiwagi","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/21645515.2016.1265715","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults \u226550 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial","volume":"13","author":"Godeaux","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","first-page":"35","article-title":"Evaluation of volume of intramuscular injection into the caudal thigh muscles of female and male BALB\/c Mice (Mus musculus)","volume":"67","author":"Gehling","year":"2018","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2001-12-0291","article-title":"Role for granulocyte colony\u2013stimulating factor in the generation of human T regulatory type 1 cells","volume":"100","author":"Rutella","year":"2002","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101344","DOI":"10.1016\/j.smim.2019.101344","article-title":"Functions and regulation of T cell-derived interleukin-10","volume":"44","author":"Neumann","year":"2019","journal-title":"Sem. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108216","DOI":"10.1016\/j.intimp.2021.108216","article-title":"Immune response of C57BL\/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants","volume":"101","author":"He","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5625\/lar.2017.33.2.119","article-title":"Use of C57\/BL\/6N mice on the variety of immunological researches","volume":"33","author":"Song","year":"2017","journal-title":"Lab Anim. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fimmu.2018.00455","article-title":"Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Le, N.P.K., Herz, C., Gomes, J.V.D., F\u00f6rster, N., Antoniadou, K., Mittermeier-Kle\u00dfinger, V.K., Mewis, I., Dawid, C., Ulrichs, C., and Lamy, E. (2021). Comparative anti-inflammatory effects of Salix cortex extracts and acetylsalicylic acid in SARS-CoV-2 peptide and LPS-activated human in vitro systems. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136766"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1339\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:11:28Z","timestamp":1760141488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["vaccines10081339"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10081339","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]}}}